Home › NDC Lookup › RxCUI directory › RxCUI 1730187

{1 (aspirin 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine bitartrate 7.8 MG... — RxCUI 1730187

RxNorm drug concept · Generic pack
RxCUI 1730187 Generic pack · GPCK ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1730187
Official name{1 (aspirin 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) / 1 (aspirin 500 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known as1 daytime (aspirin 325 MG / dextromethorphan HBr 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) / 1 nighttime (aspirin 500 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) Pack
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. The injection raises low blood pressure during anesthesia and, for some products, septic shock. Eye drops dilate the pupil, nasal products relieve conges...
  • Be careful. Over-the-counter phenylephrine should not be used with a prescription MAOI or within 2 weeks of stopping one. If you aren't sure whether your medicine is an MAOI, ask m...
  • With the injection, the most common are nausea, vomiting and headache. Call for help right away if you have chest pain, a very slow heartbeat, or pain or skin changes around the IV...
  • Stop and talk to a doctor if you get nervousness, dizziness or sleeplessness. Also stop if symptoms last more than 7 days or come with a fever. Don't use more than the label recomm...
📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How {1 (aspirin 325 MG / dextromethorphan hydrobromi... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {1 (aspirin 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) / 1 (aspirin 500 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) } Pack RxCUI 1730187

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 9

    The active substance itself — no strength, form, or brand attached yet.

    • Aspirin 1191
    • Dextromethorphan 3289
    • Doxylamine 3642
    • Phenylephrine 8163
    • Aspirin / dextromethorphan / doxylamine / phenylephrine 1053120
    • Aspirin / dextromethorphan / phenylephrine 1053102
    • Dextromethorphan hydrobromide 102490
    • Doxylamine succinate 23665
    • +1 more in this family
  2. Dose forms 10

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aspirin / dextromethorphan / doxylamine / phenylephrine Effervescent Oral Tablet 1536502
    • Aspirin / dextromethorphan / phenylephrine Effervescent Oral Tablet 1536497
    • Aspirin / dextromethorphan hydrobromide / doxylamine succinate / phenylephrine bitartrate Effervescent Oral Tablet 2648302
    • Aspirin / dextromethorphan hydrobromide / phenylephrine bitartrate Effervescent Oral Tablet 2649008
    • Aspirin / dextromethorphan / doxylamine / phenylephrine Oral Product 1153723
    • Aspirin / dextromethorphan / phenylephrine Oral Product 1153725
    • Aspirin / dextromethorphan hydrobromide / doxylamine succinate / phenylephrine bitartrate Oral Product 2663463
    • Aspirin / dextromethorphan hydrobromide / phenylephrine bitartrate Oral Product 2662434
    • +2 more in this family
  3. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 23 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1730187 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00280-0025-01 1 KIT in 1 CARTON (0280-0025-01) * 12 TABLET, EFFERVESCENT... Alka-Seltzer Plus Severe Cold PowerFast Fizz Bayer HealthCare LLC. 2020-04-01
00280-1550-20 1 KIT in 1 CARTON (0280-1550-20) * 6 POUCH in 1 CARTON / 2... Alka-Seltzer Plus Cold Day and Night Bayer HealthCare LLC. 2018-09-14
Observed labelers: Bayer HealthCare LLC. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.